Page last updated: 2024-11-06

1-methyl-3-hydroxypyridine-2-one

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

This compound is a heterocyclic derivative of pyridine with a hydroxyl group at position 3 and a methyl group at position 1. It has been reported to exhibit various biological activities including antioxidant, anti-inflammatory, and antimicrobial properties. The compound's synthesis is often achieved through various methods, including the reaction of 3-hydroxypyridine-2-one with methyl iodide in the presence of a base. Research on 1-methyl-3-hydroxypyridine-2-one is driven by its potential as a lead compound for the development of new pharmaceuticals, particularly in the areas of inflammation, infection, and oxidative stress-related diseases.'

Cross-References

ID SourceID
PubMed CID88026
CHEMBL ID52209
SCHEMBL ID1298799
MeSH IDM0138859

Synonyms (29)

Synonym
1-mhpo
CHEMBL52209 ,
3-hydroxy-1-methylpyridin-2(1h)-one
19365-01-6
3-hydroxy-1-methylpyridin-2-one
1-methyl-3-hydroxypyridine-2-one
2(1h)-pyridinone, 3-hydroxy-1-methyl-
1-methyl-3-hydroxypyrid-2-one
SCHEMBL1298799
1-methyl-3-hydroxy-2(1h)-pyridinone
AKOS006343103
3-hydroxy-1-methylpyrid-2-one
3-hydroxy-1-methyl-1h-pyridin-2-one
1-methyl-2-oxo-1,2-dihydro-pyridin-3-ol
QUKDWRYJPHUXQR-UHFFFAOYSA-N
mfcd11848440
DTXSID00172973
3-hydroxy-1-methyl-1,2-dihydropyridin-2-one
GS-6007
n-methyl-3-hydroxy-2-pyridone
gqv ,
1-methyl-3-oxidanyl-pyridin-2-one
FT-0712990
A911487
SB53719
CS-0172427
EN300-204026
bdbm50601364
Z1201625929
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Glutaminyl-peptide cyclotransferaseHomo sapiens (human)IC50 (µMol)772.00005.00005.00005.0000AID1893771
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (2)

Processvia Protein(s)Taxonomy
peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferaseGlutaminyl-peptide cyclotransferaseHomo sapiens (human)
protein modification processGlutaminyl-peptide cyclotransferaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (3)

Processvia Protein(s)Taxonomy
protein bindingGlutaminyl-peptide cyclotransferaseHomo sapiens (human)
zinc ion bindingGlutaminyl-peptide cyclotransferaseHomo sapiens (human)
glutaminyl-peptide cyclotransferase activityGlutaminyl-peptide cyclotransferaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (5)

Processvia Protein(s)Taxonomy
extracellular regionGlutaminyl-peptide cyclotransferaseHomo sapiens (human)
specific granule lumenGlutaminyl-peptide cyclotransferaseHomo sapiens (human)
extracellular exosomeGlutaminyl-peptide cyclotransferaseHomo sapiens (human)
tertiary granule lumenGlutaminyl-peptide cyclotransferaseHomo sapiens (human)
ficolin-1-rich granule lumenGlutaminyl-peptide cyclotransferaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (19)

Assay IDTitleYearJournalArticle
AID734739Inhibition of HDAC1 (unknown origin) after 60 mins by SAMDI spectrophotometric analysis2013Journal of medicinal chemistry, May-09, Volume: 56, Issue:9
3-Hydroxypyridin-2-thione as novel zinc binding group for selective histone deacetylase inhibition.
AID24627Compound was tested for their chelating potential (free ligand) determined by distribution coefficient method.1996Journal of medicinal chemistry, Sep-13, Volume: 39, Issue:19
Synthesis, physicochemical properties, and biological evaluation of hydroxypyranones and hydroxypyridinones: novel bidentate ligands for cell-labeling.
AID566706Inhibition of human recombinant MMP9 at 1 mM after 30 mins2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
AID566707Inhibition of mouse recombinant iNOS at 1 mM after 40 mins by colorimetric assay2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
AID1893771Inhibition of recombinant human QC using H-Gln-AMC hydrobromide as fluorogenic substrate incubated for 6 hrs by fluorometric microplate reader analysis2022ACS medicinal chemistry letters, Sep-08, Volume: 13, Issue:9
2-Amino-1,3,4-thiadiazoles as Glutaminyl Cyclases Inhibitors Increase Phagocytosis through Modification of CD47-SIRPĪ± Checkpoint.
AID566705Inhibition of human recombinant MMP8 at 1 mM after 30 mins2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
AID566703Inhibition of human recombinant MMP2 at 1 mM after 30 mins2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
AID566704Inhibition of human recombinant MMP3 at 1 mM after 30 mins2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
AID734740Inhibition of HDAC6 (unknown origin) after 60 mins by SAMDI spectrophotometric analysis2013Journal of medicinal chemistry, May-09, Volume: 56, Issue:9
3-Hydroxypyridin-2-thione as novel zinc binding group for selective histone deacetylase inhibition.
AID566702Inhibition of human recombinant MMP1 at 1 mM after 30 mins2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
AID566700Inhibition of human recombinant 5-lipoxygenase at 1 mM after 10 mins by fluorescence assay2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
AID15378Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol1990Journal of medicinal chemistry, Jun, Volume: 33, Issue:6
Novel 3-hydroxy-2(1H)-pyridinones. Synthesis, iron(III)-chelating properties, and biological activity.
AID24629Compound was tested for their chelating potential with Iron-III complex determined by distribution coefficient method.1996Journal of medicinal chemistry, Sep-13, Volume: 39, Issue:19
Synthesis, physicochemical properties, and biological evaluation of hydroxypyranones and hydroxypyridinones: novel bidentate ligands for cell-labeling.
AID24630Compound was tested for their chelating potential with gallium-III complex determined by distribution coefficient method.1996Journal of medicinal chemistry, Sep-13, Volume: 39, Issue:19
Synthesis, physicochemical properties, and biological evaluation of hydroxypyranones and hydroxypyridinones: novel bidentate ligands for cell-labeling.
AID566699Inhibition of mushroom tyrosinase at 1 mM after 10 mins2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
AID566701Inhibition of recombinant anthrax lethal factor at 1 mM after 30 mins by fluorescence assay2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
AID15379Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol1990Journal of medicinal chemistry, Jun, Volume: 33, Issue:6
Novel 3-hydroxy-2(1H)-pyridinones. Synthesis, iron(III)-chelating properties, and biological activity.
AID24628Compound was tested for their chelating potential with Indium-III complex determined by distribution coefficient method.1996Journal of medicinal chemistry, Sep-13, Volume: 39, Issue:19
Synthesis, physicochemical properties, and biological evaluation of hydroxypyranones and hydroxypyridinones: novel bidentate ligands for cell-labeling.
AID734738Inhibition of HDAC8 (unknown origin) after 60 mins by SAMDI spectrophotometric analysis2013Journal of medicinal chemistry, May-09, Volume: 56, Issue:9
3-Hydroxypyridin-2-thione as novel zinc binding group for selective histone deacetylase inhibition.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (14.29)18.7374
1990's2 (28.57)18.2507
2000's0 (0.00)29.6817
2010's3 (42.86)24.3611
2020's1 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.84

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.84 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.92 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.84)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]